Skip to main content
OpenTrials

Clinical trial condition

Thrombotic Microangiopathies

Explore clinical trials studying Thrombotic Microangiopathies. Study availability and eligibility vary by location and protocol.

395 public trials 101 recruiting studies
Refine in advanced search Browse all conditions

Thrombotic Microangiopathies trial results

Completed

RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag

NCT00370331

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • GSK Investigational Site Duarte, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Washington D.C., District of Columbia, United States
View all 115 locations
View Trial Details
Completed

EXTEND (Eltrombopag Extended Dosing Study)

NCT00351468

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Novartis Investigative Site Huntsville, Alabama, United States
  • Novartis Investigative Site Mobile, Alabama, United States
  • Novartis Investigative Site Jonesboro, Arkansas, United States
  • Novartis Investigative Site Duarte, California, United States
View all 110 locations
View Trial Details
Completed

Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura

NCT00657410

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • U.O. di Ematologia - Azienda Ospedaliera - Pia Fondazione di Culto e di Religione Card. G.Panico Tricase, (le), Italy
  • S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Azienda ospedaliera Nuovo Ospedale "Torrette" Ancona, Italy
  • USL 8 - Ospedale S.Donato Arezzo, Italy
View all 42 locations
View Trial Details
Completed

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

NCT01444417

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +20 more
Locations
  • Research Site Orange, California, United States
  • Research Site San Diego, California, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Atlanta, Georgia, United States
View all 33 locations
View Trial Details
Completed

Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients

NCT00362349

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Canberra Hospital Canberra, Australian Capital Territory, Australia
  • Royal Prince Alfred Hospital Sydney, New South Wales, Australia
  • St George Hospital Sydney, New South Wales, Australia
  • Princess Alexandra Hospital Brisbane, Queensland, Australia
View Trial Details

Related conditions